Has Nastassja Bedford-Lyon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,650 in general payments to Nastassja Bedford-Lyon, MD across 102 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nastassja Bedford-Lyon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nastassja Bedford-Lyon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nastassja Bedford-Lyon, MD

Dermatology · Toledo, OHNPI 1235627225

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 27.5% of the total. 2025 is the largest year on record at $986, 9.8 times the $100 reported in 2020. That places this record below the midpoint for dermatology clinicians in OH, where the typical reported total is $2,374.

$2,650in general payments, 2019–2025

Across 102 payments — averaging $25.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$730
AbbVie$470
Sanofi$206
UCB, Inc.$206
E.r. Squibb & Sons, L.L.C.$205
Johnson & Johnson$144
plus $689 from 15 others

What the payments were for

Food & beverage$2,57797%
Education$733%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	17	$730
AbbVie(2 entities)	30	$470
Sanofi	6	$206
UCB, Inc.	5	$206
E.r. Squibb & Sons, L.L.C.	5	$205
Johnson & Johnson	7	$144
Sun Pharmaceutical Industries Inc.	5	$100
Novartis	4	$95
Helsinn Therapeutics (U.S.), Inc.	5	$84
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$79
LEO Pharma Inc.	3	$61
Boehringer Ingelheim	2	$43
Solta Medical, A Division Of Bausch Health US, LLC	2	$37
Tactile Systems Technology Inc	2	$35
Galderma Laboratories, L.p.	2	$32
Chiesi USA, Inc.	1	$25
Organon	1	$23
Lilly USA, LLC	1	$22
Organogenesis Inc.	1	$20
Kyowa Kirin, Inc.	1	$16
Incyte Corporation	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,650 in reported general payments places this provider in the 50th percentile of 460 dermatology providers in Ohio.

See all dermatology providers in Ohio →

Medicare billing

Part B allowed, 2024

$37,842

Medicare patients

175

Services billed

679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	12	$168,793
Dupixent PenDupilumab	22	$79,037
Ivermectin	14	$5,341
Clobetasol Propionate	117	$4,997
Ketoconazole	140	$2,119
Triamcinolone Acetonide	108	$1,472
Betamethasone Dipropionate	24	$1,315
Clindamycin Phosphate	37	$1,082
Ammonium Lactate	40	$499
Doxycycline Hyclate	16	$496
Doxycycline Monohydrate	15	$421
Minoxidil	18	$180
Hydrocortisone	31	$128

Paid to pharmacies, not to this prescriber.

Other dermatology in Toledo

Lorie GottwaldToledo$460K
Krishna MutgiToledo$108K
Matthew ZirwasBexley$3.3M
George DrewMarion$1.9M
Rocco SerraoDayton$1.7M
James LibeccoFairlawn$1.1M
Pranav ShethWest Chester$978K
Dawn MerrittAthens$844K
Neil KormanCleveland$824K
Joshua GrosshandlerWesterville$479K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →